CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 44

Industry reads hand-picked by our editors

Aug 09, 2024

The 19th
IUD insertion is painful. For the first time, the CDC issued guidance for physicians.
Science
Bold new strategy to suppress HIV passes first
Bloomberg
23andMe’s Quarterly Sales Miss Estimates as CEO Seeks Control

Aug 08, 2024

MIT Technology Review
How covid conspiracy theories led to an alarming resurgence in AIDS denialism
Fierce Biotech
Lilly faces Phase 2 failure of tau-targeting med
FirstWord Pharma
BMS under FDA fire for misleading efficacy claims on Krazati website
Bloomberg
What Happens When Ozempic Takes Over Your Town

Aug 07, 2024

Financial Times
Roche considers options for $1.9bn cancer data start-up
Bloomberg
Novo Owner Bets Gene Analysis Firm Can Help Make Cancer Vaccines
ApexOnco
Blood cancer gene therapies enter the clinic

Aug 06, 2024

C&EN
Sickle cell disease in India: The quest for a cure
Stat
‘Jerking families around’: Canceled Roche rare disease trial devastates parents, angers researchers
FirstWord Pharma
New Jersey site bears brunt of further BMS layoffs

Aug 05, 2024

The Wall Street Journal
Ecstasy Drug Trials Missed Suicidal Thoughts of Subjects
Reuters
Mallinckrodt to sell Therakos unit to CVC Capital for $925 mln
FirstWord Pharma
BioNTech’s Q2 losses quadruple as it banks on cancer-focused future

Aug 02, 2024

Financial Times
How medical research is failing women
The Economist
Gene-editing drugs are moving from lab to clinic at lightning speed
Reuters
Sanofi to invest 1.3 bln euros in new insulin plant in Frankfurt

Aug 01, 2024

Bloomberg
Almost Half of Dementia Cases Can Be Fended Off, Study Says
NPR
Can a lobbying push led by veterans help MDMA get approved for PTSD treatment?
MIT Technology Review
A controversial Chinese CRISPR scientist is still hopeful about embryo gene-editing. Here’s why.

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
Structuring Unstructured Data for the Next Generation of Complex Trials Custom content for IMO Health
Trendline
The state of vaccine development in pharma Supported by Thermo Fisher Scientific
Trendline
The latest developments in oncology research Supported by CG Life

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

4 major trends shaping today’s oncology market Webinar - on demand • Provided by Advisory Board
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.